Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
0.701
-0.028 (-3.82%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Trinity Biotech Revenue
Trinity Biotech had revenue of $14.31M in the quarter ending September 30, 2025, a decrease of -5.54%. This brings the company's revenue in the last twelve months to $48.57M, down -17.85% year-over-year. In the year 2024, Trinity Biotech had annual revenue of $61.56M with 8.31% growth.
Revenue (ttm)
$48.57M
Revenue Growth
-17.85%
P/S Ratio
0.27
Revenue / Employee
$121,122
Employees
401
Market Cap
13.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 61.56M | 4.72M | 8.31% |
| Dec 31, 2023 | 56.83M | -5.69M | -9.10% |
| Dec 31, 2022 | 62.52M | -18.63M | -22.96% |
| Dec 31, 2021 | 81.15M | -20.83M | -20.43% |
| Dec 31, 2020 | 101.98M | 11.55M | 12.77% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IRIDEX | 50.65M |
| Lifeward | 24.50M |
| Vivos Therapeutics | 17.32M |
| Beyond Air | 6.92M |
| Tenon Medical | 3.23M |
| Sintx Technologies | 1.27M |
| Movano | 500.00K |
| Nexalin Technology | 156.93K |
TRIB News
- 12 days ago - Trinity Biotech Secures $25 Million Financing Commitment to Support Growth Initiatives - GlobeNewsWire
- 17 days ago - Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares - GlobeNewsWire
- 24 days ago - Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 27 days ago - Trinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold™ HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation - GlobeNewsWire
- 27 days ago - Trinity Biotech Glucose Monitoring Innovation Achieves Unique Global Recognition: Diabetes Care Premier Hb9210™ HbA1c Analyser Becomes the Only System Awarded Prestigious IFCC Gold Classification for 2026 - GlobeNewsWire
- 2 months ago - Trinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives - GlobeNewsWire
- 2 months ago - Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests - GlobeNewsWire
- 3 months ago - Trinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances - GlobeNewsWire